Clinical Pathway for Pancreatic Enzyme Replacement Therapy (PERT) in Children with or at Risk for Exocrine Pancreatic Insufficiency (EPI)
Clinical Pathway for Pancreatic Enzyme Replacement Therapy (PERT) in Children with or at Risk for Exocrine Pancreatic Insufficiency (EPI)
Acquired Pancreatic Insufficiency (API)
Patients with previously normal exocrine function may lose function secondary to another process. Some of these are detailed in the table below.
Common Secondary Causes of API | Clinical Presentation/Disease Process |
---|---|
Pancreatectomy |
|
Inflammatory Destruction of Pancreatic Acini |
|
Inactivation/Loss of Digestive Enzymes |
|
Malignancy |
|
Atrophy |
|